BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23866864)

  • 1. Treatment of mucous membrane pemphigoid with rituximab.
    Heelan K; Walsh S; Shear NH
    J Am Acad Dermatol; 2013 Aug; 69(2):310-1. PubMed ID: 23866864
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Treatment of mucous membrane pemphigoid with rituximab".
    Ahmed AR; Shetty S
    J Am Acad Dermatol; 2013 Aug; 69(2):311-2. PubMed ID: 23866865
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
    Shetty S; Ahmed AR
    J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for patients with refractory mucous membrane pemphigoid.
    Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
    Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
    Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
    Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
    [No Abstract]   [Full Text] [Related]  

  • 6. Taking responsibility for complex medical dermatology patient management.
    Zone JJ
    Arch Dermatol; 2011 Jul; 147(7):850. PubMed ID: 21768485
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?
    Hertl M; Bernard P; Borradori L
    Arch Dermatol; 2011 Jul; 147(7):855-6. PubMed ID: 21768487
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab.
    He Y; Shimoda M; Ono Y; Villalobos IB; Mitra A; Konia T; Grando SA; Zone JJ; Maverakis E
    JAMA Dermatol; 2015 Jun; 151(6):646-50. PubMed ID: 25901938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to patients with mucous membrane pemphigoid.
    Kourosh AS; Yancey KB
    Dermatol Clin; 2011 Oct; 29(4):637-41. PubMed ID: 21925010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reframing risk part I: Legal and ethical standards for medical risk disclosure.
    Stoff BK; Cruze D; Swerlick RA
    J Am Acad Dermatol; 2013 Oct; 69(4):634-6. PubMed ID: 24034367
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in mucous membrane pemphigoid.
    Daniel E; Thorne JE
    Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucous membrane pemphigoid.
    Xu HH; Werth VP; Parisi E; Sollecito TP
    Dent Clin North Am; 2013 Oct; 57(4):611-30. PubMed ID: 24034069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatologic management of ocular mucous membrane (cicatricial) pemphigoid with mycophenolate mofetil in 38 patients.
    Hrin ML; Jorizzo JL; Feldman SR; Shah RE; Huang WW
    J Am Acad Dermatol; 2022 Sep; 87(3):653-655. PubMed ID: 34929217
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rituximab use in mucous membrane pemphigoid].
    Bertrand AS; Dereure O; Girard C; Bessis D; Guillot B
    Ann Dermatol Venereol; 2019 Oct; 146(10):659-661. PubMed ID: 31358309
    [No Abstract]   [Full Text] [Related]  

  • 20. [Involvement of mucous membranes in autoimmune bullous diseases].
    Günther C
    Hautarzt; 2016 Oct; 67(10):774-779. PubMed ID: 27631412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.